These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 31881933)

  • 1. Predicting the serum digoxin concentrations of infants in the neonatal intensive care unit through an artificial neural network.
    Yao SH; Tsai HT; Lin WL; Chen YC; Chou C; Lin HW
    BMC Pediatr; 2019 Dec; 19(1):517. PubMed ID: 31881933
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of hemodynamically significant patent ductus arteriosus on acute kidney injury and systemic hypertension in extremely low gestational age newborns.
    Velazquez DM; Reidy KJ; Sharma M; Kim M; Vega M; Havranek T
    J Matern Fetal Neonatal Med; 2019 Oct; 32(19):3209-3214. PubMed ID: 29642731
    [No Abstract]   [Full Text] [Related]  

  • 3. Digoxin therapy in low-birth-weight infants with patent ductus arteriosus.
    Berman W; Dubynsky O; Whitman V; Friedman Z; Maisels MJ
    J Pediatr; 1978 Oct; 93(4):652-5. PubMed ID: 702246
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increase in serum digoxin concentrations after indomethacin therapy in a full-term neonate.
    Haig GM; Brookfield EG
    Pharmacotherapy; 1992; 12(4):334-6. PubMed ID: 1518732
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neonatal Intensive Care Unit-Level Patent Ductus Arteriosus Treatment Rates and Outcomes in Infants Born Extremely Preterm.
    Isayama T; Kusuda S; Reichman B; Lee SK; Lehtonen L; Norman M; Adams M; Bassler D; Helenius K; Hakansson S; Yang J; Jain A; Shah PS;
    J Pediatr; 2020 May; 220():34-39.e5. PubMed ID: 32145968
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of indomethacin on digoxin pharmacokinetics in preterm infants.
    Koren G; Zarfin Y; Perlman M; MacLeod SM
    Pediatr Pharmacol (New York); 1984; 4(1):25-30. PubMed ID: 6739184
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intravenous indometacin in preterm infants with symptomatic patent ductus arteriosus. A population pharmacokinetic study.
    Smyth JM; Collier PS; Darwish M; Millership JS; Halliday HL; Petersen S; McElnay JC
    Br J Clin Pharmacol; 2004 Sep; 58(3):249-58. PubMed ID: 15327584
    [TBL] [Abstract][Full Text] [Related]  

  • 8. What happens when the patent ductus arteriosus is treated less aggressively in very low birth weight infants?
    Kaempf JW; Wu YX; Kaempf AJ; Kaempf AM; Wang L; Grunkemeier G
    J Perinatol; 2012 May; 32(5):344-8. PubMed ID: 21818064
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The 24-hour serum digoxin level as a prognosticator of dosage requirement in low-birth-weight (LBW) infants.
    Ng PK; Collins-Nakai RL
    Res Commun Chem Pathol Pharmacol; 1983 Oct; 42(1):71-9. PubMed ID: 6648043
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Digoxin therapy and left ventricular performance in premature infants with patent ductus arteriosus.
    Lundell BP; Boréus LO
    Acta Paediatr Scand; 1983 May; 72(3):339-43. PubMed ID: 6880719
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacologic management of patent ductus arteriosus.
    Bhatt V; Nahata MC
    Clin Pharm; 1989 Jan; 8(1):17-33. PubMed ID: 2643499
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Parameter selection for and implementation of a web-based decision-support tool to predict extubation outcome in premature infants.
    Mueller M; Wagner CL; Annibale DJ; Knapp RG; Hulsey TC; Almeida JS
    BMC Med Inform Decis Mak; 2006 Mar; 6():11. PubMed ID: 16509967
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of Patent Ductus Arteriosus Ligation With Death or Neurodevelopmental Impairment Among Extremely Preterm Infants.
    Weisz DE; Mirea L; Rosenberg E; Jang M; Ly L; Church PT; Kelly E; Kim SJ; Jain A; McNamara PJ; Shah PS
    JAMA Pediatr; 2017 May; 171(5):443-449. PubMed ID: 28264088
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Treatment of patent ductus arteriosus in preterm infants].
    Jaso E; Tejedor JC; Quero J; Pérez Rodríguez J; Agustí B; Castro J; García Frías E
    An Esp Pediatr; 1982 Jun; 16(6):449-58. PubMed ID: 7125398
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ibuprofen for the treatment of patent ductus arteriosus in preterm and/or low birth weight infants.
    Ohlsson A; Walia R; Shah S
    Cochrane Database Syst Rev; 2008 Jan; (1):CD003481. PubMed ID: 18254020
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Variation and comparative effectiveness of patent ductus arteriosus pharmacotherapy in extremely low birth weight infants.
    ElHassan NO; Bird TM; King AJ; Ambadwar PB; Jaquiss RD; Kaiser JR; Robbins JM
    J Neonatal Perinatal Med; 2014 Jan; 7(3):229-35. PubMed ID: 25322995
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of oral and intravenous Ibuprofen for medical closure of patent ductus arteriosus: which one is better?
    Olukman O; Calkavur S; Ercan G; Atlihan F; Oner T; Tavli V; Kultursay N
    Congenit Heart Dis; 2012; 7(6):534-43. PubMed ID: 22613269
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association between early echocardiography, therapy for patent ductus arteriosus, and outcomes in very low birth weight infants.
    Lee JH; Greenberg RG; Quek BH; Clark RH; Laughon MM; Smith PB; Hornik CP
    Cardiol Young; 2017 Nov; 27(9):1732-1739. PubMed ID: 28625190
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Surgical closure of patent ductus arteriosus in preterm infants at neonatal intensive care unit.
    Lin CT; Liu WH; Cheng BC; Wang LY; Chen TJ
    Acta Paediatr Taiwan; 2003; 44(5):287-91. PubMed ID: 14964985
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Base excess and hematocrit predict response to indomethacin in very low birth weight infants with patent ductus arteriosus.
    Mydam J; Rastogi A; Naheed ZJ
    Ital J Pediatr; 2019 Aug; 45(1):107. PubMed ID: 31439021
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.